Detailed View
VRTX - Vertex Pharmaceuticals Incorpor
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
141,658,046,464
Adj EBIT (TTM)
5,466,200,000
Enterprise Value
133,805,646,464
Last Price
558.89
Earnings Yield
4.09%
Return on Capital
24.86%
Capital
21,984,600,000
1Y Price Chart
Last Price: $558.89
1Y Change: 33.96%
As of 2026-10-30 | 1Y Change: 33.96%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 3,333,900,000 | 1,246,900,000 |
| 2026-03-31 | 10-Q | 2026 | 2,986,900,000 | 1,138,100,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 3,190,000,000 | 1,205,900,000 |
| 2025-09-30 | 10-Q | 2025 | 3,076,400,000 | 1,186,200,000 |
| 2025-06-30 | 10-Q | 2025 | 2,964,700,000 | 1,151,100,000 |
| 2025-03-31 | 10-Q | 2025 | 2,770,200,000 | 1,031,100,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 2,912,000,000 | 1,026,000,000 |
| 2024-09-30 | 10-Q | 2024 | 2,771,900,000 | 1,116,300,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.